Acute Pancreatitis : Comparison of Various Scores in Predicting Severity and Outcome
Launched by SOHAG UNIVERSITY · Jan 31, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at different scoring systems that help doctors understand how severe a patient's acute pancreatitis is and what the likely outcome will be. Acute pancreatitis is a sudden inflammation of the pancreas, and knowing its severity can help guide treatment and improve patient care. The study will compare various methods to see which one works best for predicting how patients will do.
To participate, you must be 18 years or older and have been diagnosed with acute pancreatitis. The trial is not yet recruiting participants, but once it starts, those who qualify will be asked to share their health information. This study aims to improve the way healthcare providers manage and treat acute pancreatitis, ultimately helping patients receive better care. If you or someone you know might be interested, keep an eye out for updates on the trial's availability!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any patient with 18 years or above and met criteria for diagnosis of acute pancreatitis will be eligible for the study.
- Exclusion Criteria:
- • -
About Sohag University
Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported